Blueclinical Investigacao E Desenvolvimento Em Saude Lda
Blueclinical Investigacao E Desenvolvimento Em Saude Lda is recorded as a service provider in 27 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 20 of 27 trials · Latest update first
A Randomized, Open-Label, Single-Dose, Parallel-Group Study to Evaluate the Relative Bioavailability of LY03010 versus Xeplion® after Intramuscular Injection in Healthy Subjects
Sponsor Geneora Pharma (Shijiazhuang) Co. Ltd.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Operational learnings available3 trial-level findings · Read insights
- The single study center in Porto, Portugal enrolled 170 participants after screening 645 participants.
- A pre-randomization oral risperidone tolerability test was required, and subjects with hypersensitivity or high sensitivity to risperidone were excluded before investigational-product treatment.
- Participants underwent 23 venous blood collections through Day 148 (Week 21) after dosing.
These findings describe the trial, not the service provider’s performance or responsibility.
An exploratory, prospective, multicenter, randomized, double blind, placebo + sham device controlled, study to assess the safety, usability, and initial efficacy of the ViXe combination for intravesical administration of XEOMIN® in the treatment of female patients with idiopathic overactive bladder (OAB).
Sponsor Vensica Medical Ltd.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Bioequivalence of Apixaban 5 mg Film-Coated Tablets: A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects Under Fasting Conditions.
Sponsor Laboratorios Cinfa S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Comparative Bioavailability of Ruxolitinib 20 mg Film-Coated Tablets: A Single-Dose, Open-Label, Randomized, Two-Treatment, Two-Sequence, Two-Period Crossover Study in Healthy Participants Under Fasting Conditions.
Sponsor Bluepharma Industria Farmaceutica S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Phase IIa Proof-of-Concept Study, with Dose-Titration Based on Treat-to-Target Strategy, to Investigate the Efficacy, Safety, and Tolerability of Subcutaneous Injection of Folate-based Liposomes Encapsulating Methotrexate (FBL-MTX) in Disease-modifying Antirheumatic Drugs (DMARD)-naïve Patients with Moderate-to-Severe Active Rheumatoid Arthritis and in Patients with an Inadequate Response or Intolerance to Oral MTX.
Sponsor Solfarcos Solucoes Farmaceuticas E Cosmeticas Lda.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Bioequivalence of Tofacitinib 10 mg Film-Coated Tablets: A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects Under Fasting Conditions.
Sponsor Bluepharma Industria Farmaceutica S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Prospective, randomised, double-blind, placebo-controlled multicenter clinical trial of efficacy and safety with Dermatophagoides pteronyssinus and Dermatophagoides farinae mannan-conjugated allergoids in patients with rhinitis/rhinoconjunctivitis, allergic to Dermatophagoides pteronyssinus and/or Dermatophagoides farinae _MM09-SIT-069
Sponsor Inmunotek S.L.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Pharmacokinetics of Nicorandil 40 mg Extended-Release Capsules: A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects Under Fasting and Fed Conditions.
Sponsor Auxilius Pharma Sp. z o.o.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Prospective, randomised, double-blind, placebo-controlled multicenter clinical trial of efficacy and safety with Dermatophagoides pteronyssinus and Dermatophagoides farinae mannan-conjugated allergoids in patients with rhinitis/rhinoconjunctivitis, allergic to Dermatophagoides pteronyssinus and/or Dermatophagoides farinae_MM09-SIT-063
Sponsor Inmunotek S.L.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Single-Dose, Randomized, Open-Label, Crossover, Exploratory Bioavailability Study in Healthy Volunteers of Two Formulations of Gliclazide MR Tablets 120 mg (I.R.I.S.) and Two Diamicron® MR Tablets 60 mg (I.R.I.S.) under Fasting and Fed Conditions and Oral Solution of 60 mg Gliclazide (I.R.I.S.) under Fasting Conditions.
Sponsor Institut De Recherches Internationales Servier IRIS
- Start (EU)
- Latest update
- Estimated end
- Not reported
An Open-label, Single Arm Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Leniolisib in Pediatric Patients (Aged 1 to 6 Years) with APDS (Activated Phosphoinositide 3-Kinase Delta Syndrome) Followed by an Open-label Long-term Extension
Sponsor Pharming Technologies B.V.
- Start (EU)
- Latest update
- Estimated end
An open-label, multicenter, prospective, single-arm, exploratory study to assess role of pancreatic enzyme replacement therapy (PERT) (Creon® 25,000) in patients with Pancreatic Exocrine Insufficiency (PEI) after total gastrectomy.
Sponsor BGP Products Operations GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
Bioequivalence of Ulipristal Acetate 30 mg Tablets: A Single-Dose, Open-Label, Randomized, Two-Sequence, Two Treatment, Two-Period Crossover Study in Healthy Subjects Under Fasting Conditions.
Sponsor Laboratorios Leon Farma S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Comparative Bioavailability of Empagliflozin 25 mg Film-Coated Tablets: A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects Under Fasting Conditions.
Sponsor Tecnimede-Sociedade Tecnico-Medicinal S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase 1 Study to Investigate the Effect of Food on the Bioavailability of a Single Cytisinicline 3 mg Tablet and Evaluation of the Pharmacokinetics of Multiple 3 mg Doses (Three Times Daily) in Healthy Adult Smokers
Sponsor Achieve Life Sciences Inc.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase I, Open-Label Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytisinicline Dose
Sponsor Achieve Life Sciences Inc.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Comparative Bioavailability of Midazolam 7.5 mg/1.5 mL Oromucosal Solution (Buccolam®) Versus Midazolam 10 mg/2 mL Solution for Injection (Hypnovel®): A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects Under Fasting Conditions.
Sponsor Laboratorios Lesvi S.L.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Comparative Bioavailability and Bioequivalence of Testosterone Transdermal Gel Versus Testogel® Dosiergel 16.2 mg/g gel: A Single-Dose, Open-Label, Randomized, Full Replicate, Four-Period Crossover Study in Healthy Female Subjects Under Fasting Conditions.
Sponsor Laboratorios Leon Farma S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Bioequivalence of Eltrombopag 75 mg Film-Coated Tablets: A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects Under Fasting Conditions.
Sponsor Bluepharma Industria Farmaceutica S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A phase II randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of an oral solution of 9-Δ tetrahydrocannabinol/cannabidiol (THC/CBD) in multiple sclerosis patients with chronic neuropathic pain
Sponsor Ferraz Lynce Especialidades Farmaceuticas S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Blueclinical Investigacao E Desenvolvimento Em Saude Lda?
The 2026-10-09 snapshot links Blueclinical Investigacao E Desenvolvimento Em Saude Lda to 27 distinct CTIS trials. Recorded services include Project management, Investigator recruitment, Regulatory services, Data management, among 13 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Blueclinical Investigacao E Desenvolvimento Em Saude Lda?
The most frequently recorded therapeutic areas are Neurology. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Blueclinical Investigacao E Desenvolvimento Em Saude Lda conducted?
The linked trials record locations in 3 countries, including Portugal, Spain, Poland. These are trial locations, not confirmed office locations or countries where Blueclinical Investigacao E Desenvolvimento Em Saude Lda delivered services.
What can this page tell me about Blueclinical Investigacao E Desenvolvimento Em Saude Lda's trial experience?
Browse 27 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Blueclinical Investigacao E Desenvolvimento Em Saude Lda. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Blueclinical Investigacao E Desenvolvimento Em Saude Lda.